Financials
PDS Biotech: Business Update and Q1 2024 Results | 15-May-2024 | 14:32 | RNS |
Martlet Capital: mandate and acquisition | 13-May-2024 | 07:00 | RNS |
PDS Biotech: Clinical trial meets study endpoints | 10-May-2024 | 09:12 | RNS |
ProAxsis secures c.£1.8mn investment | 15-Apr-2024 | 07:00 | RNS |
PDS Strategy Update and 2023 Financial Results | 27-Mar-2024 | 13:34 | RNS |
Business Update | 13-Mar-2024 | 07:00 | RNS |
Exercise of Options and Issue of Shares | 05-Feb-2024 | 07:00 | RNS |
Glycotest secures $1 million investment | 23-Jan-2024 | 07:00 | RNS |
DeepTech Recycling secures £1 million... | 01-Dec-2023 | 07:00 | RNS |
PDS BioTechnology: Third Quarter Results | 14-Nov-2023 | 16:39 | RNS |
Director/PDMR Shareholding | 13-Nov-2023 | 07:00 | RNS |
PDS Biotech Announces Updated Survival Data | 09-Nov-2023 | 17:28 | RNS |
Ventive secures c.£900,000 investment | 06-Nov-2023 | 07:00 | RNS |
Change of Adviser | 02-Nov-2023 | 07:00 | RNS |
Exercise of Options | 13-Oct-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 65.50p |
Change Today | 1.50p |
% Change | 2.34 % |
52 Week High | 72.00 |
52 Week Low | 49.00 |
Volume | 69,942 |
Shares Issued | 23.95m |
Market Cap | £15.68m |
RiskGrade | 410 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:29 | 4,013 @ 65.60p |
16:28 | 2,250 @ 65.60p |
14:19 | 778 @ 65.60p |
11:57 | 2,900 @ 67.20p |
10:31 | 15,000 @ 67.65p |
CEO | Ilian Iliev |
CFO | Stephen Crowe |
You are here: research